Deubiquitinating enzyme JOSD2 affects susceptibility of NSCLC cells to anti-cancer drugs through DNA damage repair.
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences（2023）
摘要
Deubiquitinating enzyme JOSD2 regulates the malignant progression of NSCLC by promoting DNA damage repair pathway, and depletion of JOSD2 significantly enhances the sensitivity of NSCLC cells to DNA damage agents.
更多查看译文
关键词
DNA damage repair,Deubiquitinating enzyme,Drug sensitivity,Non-small cell lung carcinoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要